Some preliminary studies from our laboratory suggest that the interaction of ILK with glutamate receptors is of relevance in neurodegenerative diseases [15, 18] because changes in ILK expression can produce changes in downstream signaling molecules as well as changes in its scaffolding property. The gene discussed is ILK; the disease is neurodegenerative disease.